Pre- and postnatal exposure to tobacco smoke and respiratory outcomes during the first year

V Fuentes-Leonarte1, M Estarlich, F Ballester

  • 1Unit of Addictive Disorders, San Marcelino Primary Health Care Center, Valencia, Spain; Center for Public Health Research (CSISP/FISABIO), Valencia, Spain; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Indoor Air
|May 10, 2014
PubMed

Insights

Prenatal and postnatal tobacco smoke exposure significantly increases infant respiratory issues like wheezing and ear infections. Prenatal exposure showed the strongest link to adverse respiratory outcomes in infants.

Area of Science:

  • Environmental Health
  • Pediatrics
  • Respiratory Medicine

Background:

  • The distinct impacts of prenatal versus postnatal tobacco smoke exposure on infant respiratory health remain unclear.
  • Understanding these effects is crucial for developing targeted preventive strategies.

Purpose of the Study:

  • To evaluate the association between prenatal and postnatal tobacco smoke exposure and the risk of respiratory conditions in infants during their first year of life.
  • To differentiate the roles of exposure timing (prenatal vs. postnatal) in infant respiratory health.

Main Methods:

  • A Spanish multicenter cohort study followed 2506 women through delivery, with 2039 infants included in the final analysis.
  • Respiratory outcomes included otitis, persistent cough, lower respiratory tract symptoms (wheezing, chestiness), and infections (bronchitis, bronchiolitis, pneumonia).
  • Logistic regression analysis was used to explore relationships between tobacco smoke exposure and health outcomes.

Main Results:

  • Maternal smoking during pregnancy was linked to increased odds of infant wheezing (OR: 1.41) and chestiness (OR: 1.46).
  • Postnatal exposure, specifically from fathers, was associated with a higher risk of otitis (OR: 1.25).
  • Passive workplace smoke exposure for non-smoking mothers during pregnancy correlated with infant cough (OR: 1.62).

Conclusions:

  • Exposure to tobacco smoke, both prenatal and postnatal, elevates the risk of various respiratory problems in infants.
  • Prenatal exposure demonstrated the most significant association with the analyzed respiratory outcomes, highlighting its critical role.

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.1K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
31
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
35
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K